Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) FCF Margin: 2009-2020

Historic FCF Margin for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2020 value amounting to 20.81%.

  • Neurocrine Biosciences' FCF Margin rose 2700.00% to 18.95% in Q3 2021 from the same period last year, while for Sep 2021 it was 30.65%, marking a year-over-year increase of 932.00%. This contributed to the annual value of 20.81% for FY2020, which is 402.00% up from last year.
  • According to the latest figures from FY2020, Neurocrine Biosciences' FCF Margin is 20.81%, which was up 23.93% from 16.79% recorded in FY2019.
  • Neurocrine Biosciences' 5-year FCF Margin high stood at 20.81% for FY2020, and its period low was -735.26% during FY2016.
  • Its 3-year average for FCF Margin is 18.19%, with a median of 16.98% in 2018.
  • In the last 5 years, Neurocrine Biosciences' FCF Margin plummeted by 53,359bps in 2016 and then spiked by 69,212bps in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' FCF Margin stood at -735.26% in 2016, then spiked by 6,012bps to -675.14% in 2017, then surged by 69,212bps to 16.98% in 2018, then dropped by 19bps to 16.79% in 2019, then soared by 402bps to 20.81% in 2020.